tirzepatide clinical trial weight loss results Alternative dosing regimens of GLP-1 receptor agonists may reduce costs and maintain efficacy Semaglutide vs Tirzepatide: Which GLP-1
Description
Disclaimer This article is intended for educational purposes only and should not be considered medical advice

tirzepatide 15 mg, n = 311
Current BPC-157 users who are adding GLP-1 therapy and want to confirm the two are compatible

What Are the Available Doses

SURPASS-2, a head-to-head trial against semaglutide 1mg, showed that Tirzepatide 5mg, 10mg, and 15mg produced greater HbA1c reductions (up to 2.6%) and weight loss (up to 12.4kg at 40 weeks) compared to semaglutide

If needed, the dosage can be increased to 10 mg once weekly in weeks 13- 16, 12.5 in weeks 17-20, and 15 mg in weeks 21-24